← Back to Search

Study participants for Late-Life Depression

N/A
Waitlist Available
Research Sponsored by University of California, Riverside
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will focus on helping to mitigate depression and isolation among older people living with HIV, as these have become deep concerns especially during the COVID-19 pandemic.

Eligible Conditions
  • HIV (Human Immunodeficiency Virus)
  • Late-Life Depression
  • Social Isolation
  • Aging

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in depression after pilot testing virtual village

Trial Design

1Treatment groups
Experimental Treatment
Group I: Study participantsExperimental Treatment1 Intervention
No participants will be randomized. All participants will have an opportunity to participate in the study procedures.

Find a Location

Who is running the clinical trial?

University of California, RiversideLead Sponsor
24 Previous Clinical Trials
12,176 Total Patients Enrolled
University of South FloridaOTHER
412 Previous Clinical Trials
186,979 Total Patients Enrolled
University of Southern CaliforniaOTHER
906 Previous Clinical Trials
1,596,208 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby Apr 2025